A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors

Category Primary study
JournalJournal for ImmunoTherapy of Cancer
Year 2013
This article has no abstract
Epistemonikos ID: 15cf254f8384dc6209c57cfa4ef5ddb874f1e23b
First added on: Feb 07, 2025